Carnegie acted as sole global co-ordinator and sole bookrunner in the directed share issue of 2.85 million new class B shares at a subscription price of SEK 400 per share. BioGaia is an innovative Swedish healthcare company that develops, markets and sells probiotic products with documented health benefits. November 2020.
Healthcare
Directed share issue in BioGaia AB (SE) — SEK 1.1 billion
November 2020